Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets
Journal:
Current Drug Targets
Volume:
13
Page:
1360-1374
Author(s):
Thomas Ve, Nicholas J. Gay, Ashley Mansell, Bostjan Kobe and Stuart Kellie
Innovative Topical Formulations for Treatment of Dermatitis
Journal:
Recent Patents on Inflammation & Allergy Drug Discovery
Volume:
6
Page:
186-201
Author(s):
Taner Senyigit, Ipek Ozcan and Ozgen Ozer
Non-steroidal Anti-Inflammatory Drugs and Melanoma
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3966-3978
Author(s):
Virginia Sanz-Motilva, Antonio Martorell-Calatayud and Eduardo Nagore
Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3664-3678
Author(s):
N. B. Janakiram, A. Mohammed, M. S. Bronze and C. V. Rao
Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
607-616
Author(s):
Z. Zuo, W. Ouyang, J. Li, M. Costa and C. Huang
Revising Skin Cancers by Means of Epigenetic Markers
Journal:
Recent Patents on Biomarkers
Volume:
2
Page:
93-98
Author(s):
Carolina Constantin and Sabina A. Zurac
Drug Targeting Strategies for Photodynamic Therapy
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
12
Page:
500-525
Author(s):
Frederic Schmitt and Lucienne Juillerat-Jeanneret
Spinophilin: A New Tumor Suppressor at 17q21
Journal:
Current Molecular Medicine
Volume:
12
Page:
528-535
Author(s):
A. Carnero
Pilot Randomized Controlled Study of a Histamine Receptor Inverse Agonist in the Symptomatic Treatment of AD
Journal:
Current Alzheimer Research
Volume:
9
Page:
481-490
Author(s):
Michael Egan, Roy Yaari, Lian Liu, Michael Ryan, Yahong Peng, Christopher Lines and David Michelson
Nanostructural Hybrid Sensitizers for Photodynamic Therapy
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2607-2621
Author(s):
Mariusz Kepczynski, Monika Dzieciuch and Maria Nowakowska